Related Experiment Video
Updated: Aug 29, 2025

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
[How can more patients benefit from epilepsy surgery?]
1docent, överläkare, båda institutionen för neurovetenskap och fysiologi samt Wallenbergcentrum för molekylär och translationell medicin, Göteborgs universitet; Neurosjukvården, Sahlgrenska universitetssjukhuset, Göteborg.
Advances in epilepsy surgery offer new hope for patients with drug-resistant epilepsy. Recent guidelines aim to improve patient identification and access to advanced surgical evaluations in Swedish healthcare.
Area of Science:
- Neurology
- Neurosurgery
- Public Health
Background:
- Epilepsy surgery has seen significant advancements, expanding treatment options.
- Identifying suitable candidates for epilepsy surgery remains a challenge.
- Access to advanced epilepsy evaluations and treatments is uneven across Sweden.
Purpose of the Study:
- To highlight recent progress in epilepsy surgery.
- To emphasize the need for improved patient identification for epilepsy surgery in Sweden.
- To address obstacles hindering access to epilepsy surgery.
Main Methods:
- Review of recent advancements in epilepsy surgery.
- Analysis of factors contributing to physician delay in referrals.
- Examination of capacity for advanced evaluations and geographical disparities.
- Evaluation of the impact of new national guidelines.
Main Results:
- Significant progress in epilepsy surgery techniques and outcomes.
- Identification of physician delay, evaluation capacity, and geographical inequality as key barriers.
- Introduction of national guidelines by the National Board of Health and Welfare.
Conclusions:
- Renewed efforts are needed in Swedish healthcare to identify and refer patients for epilepsy surgery.
- National guidelines offer a framework to mitigate existing obstacles.
- Improved access to epilepsy surgery can enhance patient outcomes for those with pharmacoresistant epilepsy.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electroconvulsive Therapy
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

